A21T (p.Ala21Thr) variant of CDH2 (Cadherin-2)

A21T (p.Ala21Thr) in CDH2 (Cadherin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as benign/likely benign in the context of not provided; not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.32 / 1. The record also includes population frequency data and structural context.

A21T (p.Ala21Thr) variant details